You
FiltersClear all
Kind

Style

Leads with

Best for

Industry

Origin

Era · first seen
Uses first seen. Date created is rarely published.
Length

50 closest statements

by meaning · ranked by similarity · 100 per page

Meaning search returns the 50 nearest statements, then applies your filters.

EQ
EQRx, Inc.Company · Health · MA
Real
“Our mission is to improve health for all with great, innovative, affordable medicines so that people with life-changing or chronic conditions can gain access to the medicines they need, physicians can treat patients without barriers to prescribing, and health systems can afford to make those medicines available, without restrictions, to the populations they serve in a financially sustainable manner.”
MissionDemocratizationLeads with accessMission-driven
In use 2022 – now·1 sighting·SEC Form 10-K, filed 2022-03-2352% match
AH
Adeptus Health Inc.Company · Health · TX
Real
“The Recovery Audit Program's mission is to identify and correct Medicare improper payments through the efficient detection and collection of overpayments made on claims of healthcare services provided to Medicare beneficiaries, and the identification of underpayments to providers so that the CMS can implement actions that will prevent future improper payments.”
MissionProblem–solutionLeads with problemClimate & health
In use 2016 – now·1 sighting·SEC Form 10-K, filed 2016-02-2952% match
IH
InfuSystem Holdings, IncCompany · Health · MI
Real
“The Patient Services segment’s core purpose is to seek opportunities to grow our business by leveraging our unique know-how in clinic-to-home healthcare solutions involving Durable Medical Equipment, our logistics and billing capabilities, 3 Table of Contents our growing network of third-party payers under contract, and our clinical and biomedical capabilities.”
MissionProduct offeringLeads with productClimate & health
In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-2751% match
6D
60 Degrees Pharmaceuticals, Inc.Company · Health · DC
Real
“Our mission is to address the unmet medical need associated with vector-borne diseases through the development and commercialization of new small molecule therapeutics, focusing on synthetic drugs (made by chemists in labs, excluding biologics) with good safety profiles based on prior clinical studies, in order to reduce cost, risk, and capitalize on existing research.”
MissionProblem–solutionLeads with problemClimate & health
In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-3049% match
Showing 1–50 of 50
0 to compareCompare